Do you know why we focus on the “Crown Jewel”?
When discussing biotech investments, the term “crown jewel” usually pertains to the lead or major therapeutic candidate that a business has in its pipeline. This medication is thought to have the highest chance of success and a major effect on the company’s future revenue growth potential. When evaluating the company’s worth and potential for profits, analysts and investors frequently concentrate on the crown jewel.
So why does it make sense to focus on the crown jewel?
- High Success Potential: It represents the most promising asset with the highest chance of success.
- Technology Validation: Its success validate the technology and innovation process of the company.
- Value Driver: Success of the crown jewel significantly impacts the company’s overall value and attracts investor interest.
- Risk Management: Concentrating resources on the primary candidate allows for better risk assessment.
- Informed Decisions: Thorough analysis of the crown jewel helps in making informed investment decisions based on its potential and risks.